Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Molecular Models02:00

Molecular Models

38.1K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
38.1K
¹H NMR: Pople Notation01:09

¹H NMR: Pople Notation

1.7K
The Pople nomenclature system classifies spin systems based on the difference between their chemical shifts. Coupled spins are denoted by capital letters with subscripts indicating the number of equivalent nuclei. When the coupled nuclei have well-separated chemical shifts, they are assigned letters that are far apart in the alphabet, such as A and X. When the difference in chemical shifts is small, coupled nuclei are named using adjacent letters of the alphabet (AB, MN, or XY).
A proton...
1.7K
¹H NMR: Complex Splitting01:13

¹H NMR: Complex Splitting

1.3K
A proton M that is coupled to a proton X results in doublet signals for M. However, NMR-active nuclei can be simultaneously coupled to more than one nonequivalent nucleus. When M is coupled to a second proton A, such as in styrene oxide, each peak in the doublet is split into another doublet.
Splitting diagrams or splitting tree diagrams are routinely used to depict such complex couplings. While drawing splitting diagrams, the splitting with the larger coupling constant is usually applied...
1.3K
Molecular Shapes01:18

Molecular Shapes

56.8K
Molecules have characteristic shapes that are crucial for their function. The arrangement of various electron groups around the central atom dictates their molecular geometry. Electron pairs in the valence shell of a central atom will adopt an arrangement that minimizes repulsions between the electron pairs by maximizing the distance between them. The valence electrons form either bonding pairs, located primarily between bonded atoms, or lone pairs.
Two regions of electron density in a diatomic...
56.8K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
2.8K
Molecules and Compounds02:38

Molecules and Compounds

55.1K
Atoms and Molecules
55.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Use of Deep Learning in RNA Therapeutic Development.

ACS nano·2026
Same author

Plug-and-play assembly of biodegradable ionizable lipids for potent mRNA delivery and gene editing in vivo.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Identification of 4,5,6,7-Tetrabromo-1<i>H</i>-benzotriazole (TBB) as a Small Molecule MESH1 Inhibitor that Suppresses Ferroptosis.

bioRxiv : the preprint server for biology·2026
Same author

TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug Delivery.

ACS nano·2025
Same author

Taking a deep dive with active learning for drug discovery.

Nature computational science·2024
Same author

Machine learning trims the peptide drug design process to a sweet spot.

Nature chemistry·2024

Related Experiment Video

Updated: Jun 14, 2025

Characterizing Lewis Pairs Using Titration Coupled with In Situ Infrared Spectroscopy
07:49

Characterizing Lewis Pairs Using Titration Coupled with In Situ Infrared Spectroscopy

Published on: February 20, 2020

9.1K

Finding the most potent compounds using active learning on molecular pairs.

Zachary Fralish1, Daniel Reker1

  • 1Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.

Beilstein Journal of Organic Chemistry
|September 3, 2024
PubMed
Summary
This summary is machine-generated.

ActiveDelta enhances active learning for molecular optimization by pairing compounds to improve potency and scaffold diversity, especially with limited data. This adaptive approach accelerates drug discovery by identifying better drug candidates faster.

Keywords:
active learningdrug designmachine learningmolecular optimizationpotency predictions

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K
Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
09:04

Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow

Published on: April 18, 2019

12.4K

Related Experiment Videos

Last Updated: Jun 14, 2025

Characterizing Lewis Pairs Using Titration Coupled with In Situ Infrared Spectroscopy
07:49

Characterizing Lewis Pairs Using Titration Coupled with In Situ Infrared Spectroscopy

Published on: February 20, 2020

9.1K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.7K
Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
09:04

Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow

Published on: April 18, 2019

12.4K

Area of Science:

  • Computational Chemistry
  • Drug Discovery
  • Machine Learning

Background:

  • Active learning accelerates molecular optimization but struggles in early stages with limited data, potentially yielding analogs with low scaffold diversity.
  • Exploitative active learning can lead to models that overfit to initial data, limiting exploration of novel chemical space.

Purpose of the Study:

  • To introduce ActiveDelta, an adaptive active learning approach using paired molecular representations to predict improvements and guide data acquisition.
  • To evaluate ActiveDelta's effectiveness in enhancing both potency and chemical diversity of identified molecular inhibitors.

Main Methods:

  • ActiveDelta was applied to graph-based deep (Chemprop) and tree-based (XGBoost) models for active learning.
  • Performance was assessed on 99 Ki benchmarking datasets, comparing ActiveDelta against standard active learning methods (Chemprop, XGBoost, Random Forest).
  • Chemical diversity was evaluated using Murcko scaffolds.

Main Results:

  • ActiveDelta implementations significantly outperformed standard active learning in identifying more potent inhibitors.
  • The approach successfully identified molecular inhibitors with greater chemical diversity based on Murcko scaffolds.
  • Deep learning models (Chemprop) trained with ActiveDelta-selected data showed improved accuracy in simulated time-split test sets.

Conclusions:

  • ActiveDelta represents a significant advancement for active learning strategies, particularly in low-data scenarios.
  • Molecular pairing approaches, like ActiveDelta, can accelerate the identification of potent and diverse drug candidates.
  • This method holds substantial potential for improving hit identification against critical drug targets.